Skip to main content
. 2012 Apr 26;48(1):52–56. doi: 10.4068/cmj.2012.48.1.52

TABLE 3.

Complication according to the type of therapeutics

graphic file with name cmj-48-52-i003.jpg

Group I: urokinase treatment group, Group II: urokinase non-treatment group. *p<0.05.